PEPTIC ULCER DISEASE

 

PEPTIC ULCER DISEASE

 

DEFINITION:

A chronic inflammatory disorder of the stomach or duodenum resulting in ulceration of the gastric or duodenal mucosa.

EPIDEMIOLOGY:

  • incidence: ?
  • age of onset:
    • gastric ulcers - before age 6
    • duodenal ulcers - after age 10 with mean age of diagnosis at 11.3 years (46% symptomatic before 10 years and 15% symptomatic before age 6 years)
  • risk factors:
    • see below

PATHOGENESIS:

1. Etiology

  • exposure to a triggering agent -> acute or chronic inflammation
  • ulcer formation
  • ulcers tend to occur whenever there is an imbalance between the protective mechanisms of the mucosa (mucous layer, bicarbonate layer, epithelial layer, submucosal layer, prostaglandin metabolism, vasculature) and harmful mechanisms to the mucosa (hyperacidity, increased pepsin, cytotoxic agents)
  • the triggering agents outlined below have been identified in precipitating this imbalance

1. Triggering Agents

  • 1. Infectious
    • Helicobacter pylori
  • 2. Drugs
    • Alcohol
    • Aspirin
    • Corticosteroids
    • Tolazoline
    • Nonsteroidal Anti-inflammatory Drugs
      • indomethacin, naproxen, ibuprofen, benoxaprofen, fenbufen
  • 3. Stress
    • burns (Curling ulcer)
    • intracranial lesions or trauma (Cushing ulcer)
    • others: shock, hypoglycemia, dehydration, renal failure, vasculitis
  • 4. Diseases
    • Antral G-Cell Hyperplasia
    • Cystic Fibrosis
    • Ectopic Gastrinoma
    • Zollinger-Ellison Syndrome
  • 2. Helicobacter Pylori

    • probably the most common cause of acute and chronic gastritis and duodenitis leading to pepetic ulcer disease
      • found in 90-100% of those with duodenal ulcers
      • found in 66-77% of those with gastric ulcers
    • a spiral urease-producing organism specific for gastric and duodenal mucosa
    • resides in the boundary between the epithelial cell surface and the overlying mucous gel where the urease degrades gastric mucin (part of the protective barrier) and a cytotoxin is produced
    • incidence of H. pylori infection increases with age:
  • in 5% of children <5 years of age
  • in 20% of adults <50 years of age
  • in 30-50% of adults >50 years of age
    • this shows that not everyone with a H. pylori infection develops peptic ulcer disease
    • H. pylori has also been associated with gastritis, gastric carcinomas, and gastric mucoid-associated lymphoid-tissue (MALT) lymphoma
    • try to rule out other causes of peptic ulcer disease (stress, drugs, diseases) before considering H. pylori infection

    3. Stress-Induced Ulcers

    • can develop within minutes to hours after the initial insult
    • due to ischemic damage -> decreased mucosal blood flow -> injury to the mucosa -> ulcer formation

    CLINICAL FEATURES:

    1. Gastrointestinal Manifestations

    • abdominal pain
    • abdominal tenderness
    • melena
    • nausea/vomiting
    • hematemesis
    • complications:
      • perforation +/- peritonitis
      • gastric cancer (with longstanding H. pylori infection)

    2. Abdominal Pain

    • onset usually an hour after meals
    • made worse after ingestion of pop (pH 2.8-3.2), pickles, vinegar, tomatoes, alcohol, spices
    • made better after eating or antacids
    • epigastric or RUQ in older children and adolescents
    • periumbilical, RLQ, or poorly localized in younger children
    • associated symptoms include nocturnal or early morning pain and feeding problems (in younger children)

    3. Types of Peptic Ulcer Disease

    1. Gastric Ulcer

    • more prevelent in those under 6 years of age
    • M = F

    2. Duodenal Ulcer

    • more prevelent in those older than 10 years of age
    • M > F

    INVESTIGATIONS:

    1. Endoscopy

    • diagnostic for peptic ulcer disease in 85% of children
    • endoscopic biopsy with culture or histology (Giemsa, Warthin-Starry stain, hematoxylineosin) is the gold standard for H. pylori infection

    2. Imaging Studies

    1. Upper GI with Small Bowel Follow-through

  • 1. Diagnostic
    • in only 47% of cases
    • high false-negative rate
      • will miss 33% of ulcers
    • high false-positive rate
      • 67% of those with radiologically-diagnosed ulcer have normal endoscopy
  • 2. Role
    • to rule out other causes of abdominal pain, i.e., antral webs, hiatus hernia, malrotation, duodenal bands
  • 3. Screening Tests for H. pylori

    • serology for IgG antibodies to H. pylori
    • breath tests of urease activity

    MANAGEMENT:

    1. Diagnosis

  • 1. Laboratory - endoscopy
  • 2. Education
    • diagnosis, epidemiology, prognosis, treatment options
  • 3. Goals of Therapy
  • 1. Prophylactic
    • with stress-induced ulcers
  • 2. Curative
    • with infectious and drug-induced ulcers
  • 3. Symptomatic Control
    • disease-induced ulcers
  • 2. Management Strategies

    1. Non-Pharmacological

  • 1. Avoidance
    • of drugs and stress
  • 2. Pharmacological

    1. H. Pylori

    1. Triple Combination
    • has a 80-90% eradication rate
    • give therapy for 14 days
      • Bismuth Compound (Pepto Bismol)
        • contains salicylate (watch for Reye's Syndrome if recent varicella or influenzae infection)
      • Metronidazole
      • Tetracycline or Amoxicillin
    • used in the first line treatment of MALT lymphoma and can lead to regression of low-grade MALT lymphomas
    2. Double Combination
    • give therapy for 14 days
      • Omeprazole
      • Amoxicillin

    2. Stress-Induced

    1. H2-Receptor Antagonists
    • IV or po cimetidine or ranitidine
    • antisecretory agents which directly inhibit gastric secretion
    • see below
    2. Sucralfate

    3. Drug-Induced

    1. Antacids
    • magnesium and aluminum-containing antacids
    • dose depends on age and size of patient
    • avoid calcium carbonate (Tums)
    2. H2-Receptor Antagonists
  • 1. Cimetidine
    • 20-40 mg/kg/day po tid-qid x 6-8 weeks (half this dose in young children & infants)
    • side effects: inhibits metabolism of theophylline, warfarin, phenytoin, diazepam, propranolol, lidocaine (decreases activity of the hepatic P450 system)
  • 2. Ranitidine
    • 2-4 mg/kg/day po bid
  •  

     

     

    Pediatric Database - PEPTIC ULCER DISEASE

    Pediatric Organization - Pedbase [at] Gmail.com